Module

Share

Program Content

Activities

  • TROP-2 in NSCLC
    Antibody‒Drug Conjugates Targeting TROP-2 in NSCLC: A Look to the Future
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 25, 2023

    Expires: July 24, 2024

  • TROP-2 ADCs
    Antibody‒Drug Conjugates Targeting TROP-2 in NSCLC: A Look to the Future
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 25, 2023

Faculty

cover img faculity

Hossein Borghaei, MS, DO

Professor and Chief, Thoracic Medical Oncology
The Gloria and Edmund M. Dunn Chair in Thoracic Oncology
Department of Hematology and Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

cover img faculity

Rebecca S. Heist, MD, MPH

Associate Professor of Medicine
Harvard Medical School
Medical Oncology
Massachusetts General Hospital
Boston, Massachusetts

cover img faculity

Melissa L. Johnson, MD

Director, Lung Cancer Research Program
Sarah Cannon Research Institute
Nashville, Tennessee

cover img faculity

Benjamin Levy, MD

Associate Professor
Johns Hopkins School of Medicine
Baltimore, Maryland

cover img faculity

Stephen V. Liu, MD

Associate Professor of Medicine
Director, Thoracic Oncology
Head, Developmental Therapeutics
Georgetown University
Washington, DC

Provided by

ProCE Banner

Supporters

AstraZeneca

Daiichi Sankyo, Inc.

Gilead Sciences, Inc.